Background Influenza illness burden is substantial, particularly among young children, older
adults, and those with underlying conditions. Initiatives are underway to develop better …

Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to cause morbidity
and mortality. Since SARS coronavirus 2 (SARS-CoV-2) was identified as the cause for …

Nationwide prospective surveillance of all-age patients with acute respiratory infections was
conducted in China between 2009‒2019. Here we report the etiological and …

Rationale: Current guidelines recommend patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …

Background During the initial COVID-19 response, Germany's Federal Government
implemented several nonpharmaceutical interventions (NPIs) that were instrumental in …

Alveolar macrophages orchestrate the response to viral infections. Age-related changes in
these cells may underlie the differential severity of pneumonia in older patients. We …

Background Shortening the duration of antibiotic therapy for patients admitted to hospital
with community-acquired pneumonia should help reduce antibiotic consumption and thus …

While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

Importance Community-acquired pneumonia (CAP) is a common occurrence in childhood;
consequently, evidence-based recommendations for its treatment are required. Objective To …